Ackermann Michael 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Oct 12, 2021
Insider Transaction Report
Form 4
Ackermann Michael
Director10% Owner
Transactions
- Sale
Common Stock
2021-10-08$25.03/sh−200$5,006→ 1,221,315 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices with the range of $25.000 to $25.06, inclusive. The Reporting Person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.